JP2023536814A5 - - Google Patents
Info
- Publication number
- JP2023536814A5 JP2023536814A5 JP2023505846A JP2023505846A JP2023536814A5 JP 2023536814 A5 JP2023536814 A5 JP 2023536814A5 JP 2023505846 A JP2023505846 A JP 2023505846A JP 2023505846 A JP2023505846 A JP 2023505846A JP 2023536814 A5 JP2023536814 A5 JP 2023536814A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence identity
- seq
- nos
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202007297P | 2020-07-30 | ||
| SG10202007297P | 2020-07-30 | ||
| PCT/SG2021/050443 WO2022025827A1 (en) | 2020-07-30 | 2021-07-30 | Method of stimulating proliferation of a cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536814A JP2023536814A (ja) | 2023-08-30 |
| JP2023536814A5 true JP2023536814A5 (enExample) | 2024-08-07 |
Family
ID=80038130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505846A Pending JP2023536814A (ja) | 2020-07-30 | 2021-07-30 | 細胞の増殖を刺激する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12421515B2 (enExample) |
| EP (1) | EP4107270A4 (enExample) |
| JP (1) | JP2023536814A (enExample) |
| KR (1) | KR20230049661A (enExample) |
| CN (1) | CN116261461A (enExample) |
| AU (1) | AU2021315341A1 (enExample) |
| CA (1) | CA3187212A1 (enExample) |
| WO (1) | WO2022025827A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3213181A1 (en) * | 2021-04-12 | 2022-10-20 | Grith Lykke Sorensen | Mfap4 and treatment of fibrosis |
| EP4547843A2 (en) | 2022-06-28 | 2025-05-07 | Lerna Biopharma Pte. Ltd. | Inhibitory nucleic acids for itfg1 |
| WO2024248738A1 (en) * | 2023-05-31 | 2024-12-05 | Agency For Science, Technology And Research | Liver cell regeneration |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932442A (en) * | 1997-09-23 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
| EP1074617A3 (en) * | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
| EP1752536A4 (en) * | 2004-05-11 | 2008-04-16 | Alphagen Co Ltd | POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME |
| WO2017184586A1 (en) * | 2016-04-18 | 2017-10-26 | The Trustees Of Columbia University In The City Of New York | Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (nash) |
| EP3452055A4 (en) * | 2016-05-06 | 2019-11-06 | Tod M. Woolf | IMPROVED METHODS FOR GENERIC MODIFICATION WITH AND WITHOUT PROGRAMMABLE NUCLEASES |
| SG11202007143UA (en) * | 2018-01-31 | 2020-08-28 | Heparegenix Gmbh | Protein kinase mkk4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| CN111154760A (zh) * | 2020-01-16 | 2020-05-15 | 中国药科大学 | 抑制人PCSK9基因表达的siRNA及其应用 |
-
2021
- 2021-07-30 WO PCT/SG2021/050443 patent/WO2022025827A1/en not_active Ceased
- 2021-07-30 JP JP2023505846A patent/JP2023536814A/ja active Pending
- 2021-07-30 EP EP21850188.0A patent/EP4107270A4/en active Pending
- 2021-07-30 AU AU2021315341A patent/AU2021315341A1/en active Pending
- 2021-07-30 KR KR1020237006971A patent/KR20230049661A/ko active Pending
- 2021-07-30 CN CN202180058683.4A patent/CN116261461A/zh active Pending
- 2021-07-30 CA CA3187212A patent/CA3187212A1/en active Pending
-
2022
- 2022-04-27 US US17/731,259 patent/US12421515B2/en active Active
- 2022-08-31 US US17/823,839 patent/US20230167440A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3472362B1 (en) | Papd5 and papd7 inhibitors for treating an hepatitis b infection | |
| AU2014351482B2 (en) | C/EBP alpha short activating RNA compositions and methods of use | |
| JP7829035B2 (ja) | アンギオテンシノゲン（ａｇｔ）タンパク質の発現を阻害する組成物及び方法 | |
| CA2604532A1 (en) | Small activating rna molecules and methods of use | |
| JP2018536689A5 (enExample) | ||
| KR20070110135A (ko) | 작은 간섭 ｒｎａ 및 이를 포함하는 ｂ형 간염 바이러스치료용 약학 조성물 | |
| JP2023506258A5 (enExample) | ||
| CN116888263A (zh) | 用于抑制血管生成素样3(angptl3)蛋白表达的组合物和方法 | |
| JP2022512735A5 (enExample) | ||
| JP2026510791A (ja) | インヒビンサブユニットベータｅ（ｉｎｈｂｅ）遺伝子の発現を阻害するための組成物および方法 | |
| Arbuthnot et al. | Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma | |
| WO2018193902A1 (ja) | マイクロｒｎａによるｂ型肝炎ウイルスに対する抗ウイルス効果 | |
| JP2024538859A5 (enExample) | ||
| Suzuki et al. | Poly (ethylene Glycol)(PEG)–OligoRNA Hybridization to mRNA Enables Fine‐Tuned Polyplex PEGylation for Spleen‐Targeted mRNA Delivery | |
| CN102028947B (zh) | Fam3b基因的抑制剂和组合物及抑制方法以及脂肪肝的疗法和抑制剂的制药用途 | |
| WO2022026648A1 (en) | Inhibition of incexact1 to treat heart disease | |
| CN100447243C (zh) | HBV特异性干涉靶位点基因及其siRNA和其在抗HBV感染中的应用 | |
| CN101948544B (zh) | FAT10基因siRNA重组模拟病毒及其制备方法和应用 | |
| CN117587006A (zh) | 一种抑制肝脏细胞中LOC157273基因表达的siRNA、组合物及其应用 | |
| JP2025512771A5 (enExample) | ||
| JP2024529930A5 (enExample) | ||
| JP2022530937A (ja) | オリゴ核酸分子及びその急性間欠性ポルフィリン症の治療における応用 | |
| CN107709561A (zh) | 修饰的siRNA及含有该修饰的siRNA的药物组合物 | |
| US20220220189A1 (en) | Compositions and methods for treatment of hemochromatosis | |
| JP2023529398A (ja) | Ｍｉｔｆ遺伝子を標的とする核酸分子及びその使用 |